<DOC>
	<DOCNO>NCT01073605</DOCNO>
	<brief_summary>To evaluate effect continuous intermittent administration Genotonorm stature short prepubertal child intra-uterine growth retardation</brief_summary>
	<brief_title>Genotropin Treatment Short Prepubertal Children With Intra-Uterine Growth Retardation</brief_title>
	<detailed_description />
	<mesh_term>Growth Disorders</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<criteria>Chronological age ( CA ) 3 10 girl Chronological age 3 12 boy Height CA 2 SD Birth length CA 2SD Endocrine disease except wellsubstituted hypothyroidism Sever chronic disease Skeletal dysplasia Known chromosomal aberration Ongoing treatment steroid Known intrauterine infection</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Short height</keyword>
	<keyword>intra-uterine growth retardation</keyword>
	<keyword>Genotonorm</keyword>
	<keyword>continuous treatment</keyword>
	<keyword>intermittent treatment</keyword>
</DOC>